Current treatments to prevent organ transplant rejection focus mainly on suppressing T cells, part of the adaptive immune ...

Influenza viruses are among the most likely triggers of future pandemics. A research team from the Helmholtz Center for ...

Studies show how spike protein changes determine the risk of viral outbreaks, offering important insights for the future ...

Sarcopenia, a hallmark of cancer cachexia, is associated with poor outcomes in chimeric antigen receptor (CAR) T-cell therapy ...

Let us delve into some of the TLR agonists in the clinic and why the careful selection of these drugs is crucial.

Non-Aspergillus invasive molds infections (NAIMIs) are uncommon but devastating causes of infection in the peri-hematopoietic ...

Immunocore reports first quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) net revenues of $93.9 million in Q1 2025, growing by 33% year-over-year ...

DelveInsight’s Non-Hodgkin Lymphoma pipeline report depicts a robust space with 200+ Non-Hodgkin Lymphoma companies working ...